Vaccines

28 Oct 2016 Opiant Pharmaceuticals, Inc. Licenses Heroin Vaccine From Walter Reed Army Institute of Research and National Institute on Drug Abuse
28 Oct 2016 Data from Phase 1 Trial of Triplex Vaccine for Control of Cytomegalovirus Published in Blood
27 Oct 2016 Sanofi Pasteur, Fiocruz, and WRAIR Agree to Collaborate on Zika Vaccine Research
26 Oct 2016 PharmaJet® and Vaccibody collaborate on HPV vaccine development
25 Oct 2016 Topline Results from Two-Year Follow-Up Study of Viaskin Peanut Show Long-Lasting and High Levels of Desensitization to Peanut
25 Oct 2016 GSK announces US regulatory submission of candidate vaccine for prevention of shingles
24 Oct 2016 Inovio Announces FDA Request for Additional Information For Phase III Program; Trial Initiation Delayed
24 Oct 2016 Aduro Biotech Reports Partial Clinical Hold to Pause Enrollment in LADD Trials
20 Oct 2016 Pfizer Awarded Grant to Evaluate Vaccine to Protect Newborns Against Group B Streptococcus Infection
19 Oct 2016 Canadian Ebola vaccine enters new trial phase
17 Oct 2016 First Patient Randomized in Multiple Dose Cohort of Phase 1/1b Trial with Transgene’s TG1050 in Chronic Hepatitis B Patients
17 Oct 2016 Hookipa Secures EUR 4.16 Million Additional Grant Support from the Austrian Research Promotion Agency (FFG) to Develop Arenavirus Vector-Based Cancer Immunotherapies
13 Oct 2016 Immunovaccine Announces Positive Phase 1 Topline Data for DepoVax(TM)-based Respiratory Syncytial Virus Vaccine Candidate
13 Oct 2016 SELLAS™ Life Sciences Announces Positive Interim Phase II Results from its WT1 Immunotherapeutic Anti-cancer Treatment in Multiple Myeloma Patients
11 Oct 2016 Positive Preclinical Data for Immunovaccine's DepoVax(TM)-based Malarial Vaccine Presented at 2016 World Vaccine Congress Europe
11 Oct 2016 VBI Vaccines Completes Pre-IND Meeting for its Glioblastoma Immunotherapy Candidate
10 Oct 2016 Allergy Therapeutics presents enhanced efficacy data in a malaria vaccine model with its novel adjuvant system
29 Sep 2016 Genocea’s Genital Herpes Immunotherapy GEN-003 Demonstrates Significant Reduction of Viral Shedding in Phase 2b Clinical Trial
28 Sep 2016 Immune Design Announces Advancement of First GLAAS™-based Allergy Program into Clinical Development
27 Sep 2016 Aduro Biotech Presents Encouraging Preclinical Data Showing Combination Synergy of its Immunotherapy and Checkpoint Inhibitors to Increase Antitumor Efficacy
26 Sep 2016 Vical Announces Initiation of a Phase 2 Trial of Its HSV-2 Therapeutic DNA Vaccine for Genital Herpes
26 Sep 2016 BARDA Grants $43.2 million USD to Sanofi Pasteur for Zika
26 Sep 2016 Sanaria® PfSPZ Vaccine Against Malaria Receives FDA Fast Track Designation
22 Sep 2016 ASIT Biotech Announces the Initiation of a Phase 2a Clinical Study of Its Second Product Candidate hdm-ASIT+TM for House Dust Mite Rhinitis
22 Sep 2016 Aimmune Therapeutics Completes and Exceeds North American Enrollment Target Ahead of Schedule in Phase 3 PALISADE Trial of AR101 for the Treatment of Peanut Allergy; Company Accelerates Plans for Real-World Experience Study in the U.S.

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top